| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 707148 | Card-20(22)-enolide, 3-[(6-deoxy-3-O-methyl-.beta.-D-galacto pyranosyl)oxy]-14-hydroxy-, (3.beta.,5.beta)- (9CI) | 0.0187206825450448 | 0.31104842 |
| NSC 72942 | DL-Noformicin | 0.0187206825450448 | 0.065431295 |
| NSC 73300 | Null | 0.0187206825450448 | 0.56433125 |
| NSC 80141 | Null | 0.0187206825450448 | -0.038568327 |
| NSC 132791 | Butyric acid, 2-hydroxy-2-methyl-, 4-ester with 1,3a.beta.,4,7,7a.alpha.,11,11a,11b.alpha.-octahydro-1.alpha.,2.alpha.,4.beta.,11.beta.-tetrahydroxy-3.alpha.,8,11a.beta.-trimethyl-2H-1,11c.beta.-(epo | 0.0208632511155816 | -0.057729127 |
| NSC 31780 | 3H-Indolium, 2-[3-(1,3-dihydro-1,3,3-trimethyl-2H-indol-2-ylidene)-1-propenyl]-1,3,3-trimethyl-, chloride (9CI) | 0.0208632511155817 | -0.048975714 |
| NSC 615441 | 1H-Dibenz[de,h]isoquinoline-1,3-dione, 2,2'- [(1,2-ethanediyldiamino)bis(1,3-propanediyl)] bis[2,3-dihydro-, dihydrochloride | 0.0208632511155817 | 0.47841893 |
| NSC 638636 | Null | 0.0208632511155817 | 0.2481834 |
| NSC 675004 | Null | 0.0208632511155817 | 0.0064491494 |
| NSC 693639 | Ethanone, 1-(2-pyrimidinyl)-, (2-benzoxazolyl)hydrazone | 0.0208632511155817 | 0.53443047 |